Search

Your search keyword '"Gentile, Sandro"' showing total 31 results
Start Over Author "Gentile, Sandro" Publisher elsevier bv
31 results on '"Gentile, Sandro"'

2. Lipohypertrophy and Insulin. An Old Dog that Needs New Tricks

Author

Huang, Jingtong, primary, Yeung, Andrea M., additional, Kerr, David, additional, Gentile, Sandro, additional, Heinemann, Lutz, additional, Al-Sofiani, Mohammed E., additional, Joseph, Jeffrey I., additional, Seley, Jane Jeffrie, additional, and Klonoff, David C., additional

Published
2023
Full Text
View/download PDF

3. A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes

Author

Bruttomesso, D., primary, Irace, C., additional, Pozzilli, P., additional, Anichini, Roberto, additional, Magiar, Alice, additional, Maria Baggiore, Cristiana, additional, Disoteo, Olga, additional, Porcu, Antonella, additional, Bonora, Enzo, additional, Trombetta, Maddalena, additional, Bruttomesso, Daniela, additional, Boscari, Federico, additional, Carrano, Mario, additional, Gisella Cavallo, Maria, additional, Giorgio Baroni, Marco, additional, Di Carlo, Alberto, additional, Casadidio, Ilaria, additional, Di Mauro, Maurizio, additional, Foglia, Angelo, additional, De Simone, Anna, additional, Frittitta, Lucia, additional, Garrapa, Gabriella, additional, Giorda, Bruno, additional, Nada Chieri, Elisa, additional, Guarino, Giuseppina, additional, Gentile, Sandro, additional, Irace, Concetta, additional, Catalano, Serena, additional, Lauro, Davide, additional, Maggi, Davide, additional, Ambrosett, Eleonora, additional, Maranghi, Marianna, additional, Pergolini, Daniela, additional, Letizia Petroni, Maria, additional, Marchignoli, Francesca, additional, Orsi, Emanuela, additional, Gaglio, Alessia, additional, Piatti, Piermarco, additional, Monti, Lucilla, additional, Pozzilli, Paolo, additional, Pieralice, Silvia, additional, Privitera, Filippo, additional, Trevisan, Roberto, additional, Albizzi, Mascia, additional, Buzzetti, Raffaella, additional, Carlone, Angela, additional, Pitocco, Dario, additional, and Tartaglione, Linda, additional

Published
2022
Full Text
View/download PDF

9. Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study

Author

Rossi, Maria Chiara, primary, Nicolucci, Antonio, additional, Ozzello, Alessandro, additional, Gentile, Sandro, additional, Aglialoro, Alberto, additional, Chiambretti, Anna, additional, Baccetti, Fabio, additional, Gentile, Francesco M., additional, Romeo, Francesco, additional, Lucisano, Giuseppe, additional, Giorda, Carlo B., additional, Fornengo, R., additional, Nada, E., additional, Ozzello, A., additional, Sciangula, L., additional, Musacchio, N., additional, Marelli, G., additional, Corsi, A., additional, Baccetti, F., additional, Paciotti, V., additional, Iannarelli, R., additional, Antenucci, D., additional, Chiaramonte, F., additional, Leotta, S., additional, Gentile, S., additional, Armentano, V., additional, Gentile, F.M., additional, Mastinu, F., additional, and Cucinotta, D., additional

Published
2019
Full Text
View/download PDF

11. Consensus on: Screening and therapy of coronary heart disease in diabetic patients

Author

Rivellese AA1, Piatti PM, Italian Intersociety Consensus G.r.o.u.p. Collaborators Piatti PM, Avogaro A, Anfossi G, Ardigo D, de Kreutzenberg SV, Inchiostro S, Rivellese AA, Trovati M, Zambon S, Zavaroni I, Arcangeli A, Lettino M, Mafrici A, Uguccioni M, Bianchi A, Cavallaro V, Monducci I, Cadeddu C, De Luca G, Manzato E., GENTILE, Sandro, Rivellese, ANGELA ALBAROSA, P. M., Piatti, Rivellese, Aa1, Piatti, Pm, Collaborators Piatti PM, Italian Intersociety Consensus G. r. o. u. p., Avogaro, A, Anfossi, G, Ardigo, D, de Kreutzenberg, Sv, Inchiostro, S, Rivellese, Aa, Trovati, M, Zambon, S, Zavaroni, I, Arcangeli, A, Gentile, Sandro, Lettino, M, Mafrici, A, Uguccioni, M, Bianchi, A, Cavallaro, V, Monducci, I, Cadeddu, C, De Luca, G, and Manzato, E.

Subjects
medicine.medical_specialty, Diabetic Cardiomyopathies, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Cardiovascular risk factors, MEDLINE, Coronary heart disease, Diabetes, Cardiovascular risk factors, Medicine (miscellaneous), Coronary Disease, Revascularization, Electrocardiography, Risk Factors, Diabetes mellitus, Myocardial Revascularization, medicine, Humans, Hypoglycemic Agents, Intensive care medicine, Antihypertensive Agents, Hypolipidemic Agents, Nutrition and Dietetics, Framingham Risk Score, medicine.diagnostic_test, business.industry, Diabetes, Evidence-based medicine, medicine.disease, Coronary heart disease, Italy, Echocardiography, Physical therapy, Cardiology and Cardiovascular Medicine, business, Platelet Aggregation Inhibitors
Abstract

The screening and best treatment for coronary heart disease in diabetic patients is still a matter of debate. For this reason the main Italian scientific societies dealing with diabetes and cardiovascular diseases have tried to finalize a document providing shared recommendations based on the available evidence on : 1) how and who to screen for coronary heart disease, 2) methodologies for the characterization of existing coronary heart disease 3) evaluation of the optimal treatment of cardiovascular risk factors and 4) appropriate revascularization procedures. For each of these points, the levels of evidence and strength of recommendations used in the Italian Standard of Care were adopted.

Published
2011
Full Text
View/download PDF

22. Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients

Author

Sasso, Ferdinando Carlo, primary, Carbonara, Ornella, additional, Cozzolino, Domenico, additional, Rambaldi, Pierfrancesco, additional, Mansi, Luigi, additional, Torella, Daniele, additional, Gentile, Sandro, additional, Turco, Salvatore, additional, Torella, Roberto, additional, and Salvatore, Teresa, additional

Published
2000
Full Text
View/download PDF

31. Acarbose vs metformin for new-onset type 2 diabetes

Author

Katherine Esposito, Antonio Ceriello, Marco Gallo, Riccardo Candido, Alberto De Micheli, Sandro Gentile, Gallo, M, Candido, R, De Micheli, A, Esposito, Katherine, Gentile, Sandro, and Ceriello, A.

Subjects
medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Type 2 diabetes, medicine.disease, law.invention, Metformin, Therapeutic approach, Endocrinology, Postprandial, Randomized controlled trial, Tolerability, law, Diabetes mellitus, Internal Medicine, medicine, Intensive care medicine, business, Acarbose, medicine.drug
Abstract

Wenying Yang and colleagues (October 18) report the fi ndings of a randomised controlled trial comparing acarbose with metformin as initial therapy for Chinese patients with newly diagnosed type 2 diabetes, showing similar tolerability and effi cacy. In addition to being the fi rst head-to-head comparison of metformin and acarbose as fi rst-line therapy for type 2 diabetes after failure of therapeutic lifestyle modifi cation, this intervention study is interesting as it is relevant to individualisation of pharmacological antidiabetic treatment in Asian adults with type 2 diabetes. Interest in personalised diabetes treatment is increasing. Personalised therapy involves an approach to clinical decisions that is applied to each individual patient and has, as a prerequisite, an accurate characterisation of that patient (phenotyping). Personalised therapy involves applying knowledge, scientifi c evidence, and common sense, and taking the realities of each individual patient’s circumstances into account. The fi nal aim is to optimise treatment responses, whilst similtaneously improving tolerability and compliance. To apply this in practice, physicians feel more comfortable having pragmatic aids such as predefi ned algorithms. Since 2010, the Italian Association of Diabetologists (Associazione Medici Diabetologi) has recognised the need to develop personalised treatment plans for patients with type 2 diabetes, taking into account the patient’s individual pattern of hyperglycaemia (phenotype), with the safest possible glycaemic control as a goal. Accordingly, tailored therapeutic algorithms have been developed for some of the most common type 2 diabetes phenotypes. These algorithms are available online in English, as a browser-operated interactive instrument. On the basis of a patient’s clinical features, the user can access a step-by-step suggested additive therapeutic approach. In fi ve of six Associazione Medici Diabetologi algorithms, alfa-glucosidase inhibitors are already considered as a fi rst pharmacological option for patients who are intolerant or have contraindications to metformin and who have predominantly postprandial hyperglycaemia. The study by Yang and colleagues shows that eastern Asian patients with newly diagnosed type 2 diabetes, a low BMI, a high dietary carbohydrate intake, and exaggerated postprandial glucose excursion can appropriately be treated with an alfa-glucosidase inhibitor as an alternative to metformin, at least in the short term, although cardiovascular eff ects of acarbose have yet to be investigated fully. This study, in our opinion, represents a creditable contribution and a step forward towards the development of population-specifi c and patho physiology-based treatment algorithms for type 2 diabetes.

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results